Mangoceuticals partner with Eli Lilly, Novo, provide access to Zepbound, Wegovy

Mangoceuticals (MGRX) announces that it has launched MangoRx Direct and PeachesRx Direct, two integrated programs that provide direct access to authentic Zepbound from Eli Lilly (LLY) and Wegovy from Novo Nordisk (NVO). These branded GLP-1 medications will be made available to both MangoRx and PeachesRx customers via Eli Lilly’s LillyDirect Self Pay Pharmacy Solutions and Novo Nordisk’s NovoCare Pharmacy. “We’re working to make world-class weight-loss treatment simple and sustainable,” said Jacob Cohen, CEO of Mangoceuticals. “For just $99/month, our medication management membership, includes unlimited telehealth visits, personalized progress tracking, and lifestyle coaching. GLP-1 medications are provided separately at fixed cash-pay pricing through LillyDirect(R) and NovoCare programs, starting as low as $499 per month with free home delivery. Patients also have the flexibility to pick up prescriptions at their neighborhood pharmacies of choice upon request. No insurance is required, making the programs ideal for self-pay, uninsured, underinsured and high-deductible patients.”